ASCO
Lifileucel's BLA is again delayed, but a 33-month update from a pivotal melanoma trial, along with early data from a frontline study, show continued potential.
ASCO Studies Show Impact of Biomarker Testing, Therapy Inequities in Black Men With Prostate Cancer
Two studies highlighted the importance of enrolling Black men in clinical trials to improve outcomes and ensure the efficacy of treatments and tests
Molecular Profiling in Pediatric Cancer Trials Continues to Prove Valuable for Treatment Matching
Premium
The GAIN/iCat2 study and the Pediatric MATCH trial showed that molecular data has a significant impact on treatment recommendations for kids with cancer.
Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications
Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions.
New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection
Cancer diagnostic firms showcased their discoveries as they flesh out their DNA methylation- and fragmentation-based platforms using circulating tumor DNA.
Jun 8, 2021
Jun 7, 2021